A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Sanofi
ClinicalTrials.gov Identifier:
NCT01455532
First received: October 7, 2011
Last updated: September 14, 2013
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2014
  Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)